{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:00:15Z","timestamp":1791975615758,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7547","license":[{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/nature14287","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T06:21:48Z","timestamp":1427696508000},"page":"317-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":347,"title":["Two disparate ligand-binding sites in the human P2Y1 receptor"],"prefix":"10.1038","volume":"520","author":[{"given":"Dandan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Guo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Kiselev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Paoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiying","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gye Won","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Cherezov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod","family":"Katritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"key":"BFnature14287_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"MP Abbracchio","year":"2006","unstructured":"Abbracchio, M. P. et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58, 281\u2013341 (2006)","journal-title":"Pharmacol. Rev."},{"key":"BFnature14287_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1160\/TH07-11-0673","volume":"99","author":"C Gachet","year":"2008","unstructured":"Gachet, C. P2 receptors, platelet function and pharmacological implications. Thromb. Haemost. 99, 466\u2013472 (2008)","journal-title":"Thromb. Haemost."},{"key":"BFnature14287_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11302-011-9216-0","volume":"7","author":"KA Jacobson","year":"2011","unstructured":"Jacobson, K. A., Deflorian, F., Mishra, S. & Costanzi, S. Pharmacochemistry of the platelet purinergic receptors. Purinergic Signal. 7, 305\u2013324 (2011)","journal-title":"Purinergic Signal."},{"key":"BFnature14287_CR4","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","volume":"95","author":"J Jin","year":"1998","unstructured":"Jin, J. & Kunapuli, S. P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl Acad. Sci. USA 95, 8070\u20138074 (1998)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature14287_CR5","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.110.002139","volume":"123","author":"M Zerr","year":"2011","unstructured":"Zerr, M. et al. Major contribution of the P2Y1 receptor in purinergic regulation of TNFalpha-induced vascular inflammation. Circulation 123, 2404\u20132413 (2011)","journal-title":"Circulation"},{"key":"BFnature14287_CR6","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1523\/JNEUROSCI.20-08-02800.2000","volume":"20","author":"SR Fam","year":"2000","unstructured":"Fam, S. R., Gallagher, C. J. & Salter, M. W. P2Y1 purinoceptor-mediated Ca2+ signaling and Ca2+ wave propagation in dorsal spinal cord astrocytes. J. Neurosci. 20, 2800\u20132808 (2000)","journal-title":"J. Neurosci."},{"key":"BFnature14287_CR7","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1523\/JNEUROSCI.23-06-02348.2003","volume":"23","author":"JT Neary","year":"2003","unstructured":"Neary, J. T., Kang, Y., Willoughby, K. A. & Ellis, E. F. Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J. Neurosci. 23, 2348\u20132356 (2003)","journal-title":"J. Neurosci."},{"key":"BFnature14287_CR8","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1021\/jm030127+","volume":"46","author":"HS Kim","year":"2003","unstructured":"Kim, H. S. et al. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. J. Med. Chem. 46, 4974\u20134987 (2003)","journal-title":"J. Med. Chem."},{"key":"BFnature14287_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1124\/jpet.105.094037","volume":"316","author":"B Hechler","year":"2006","unstructured":"Hechler, B. et al. MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2\u2032-deoxyadenosine-3\u2032,5\u2032-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice. J. Pharmacol. Exp. Ther. 316, 556\u2013563 (2006)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnature14287_CR10","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1021\/jm301708u","volume":"56","author":"H Chao","year":"2013","unstructured":"Chao, H. et al. Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists. J. Med. Chem. 56, 1704\u20131714 (2013)","journal-title":"J. Med. Chem."},{"key":"BFnature14287_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature11701","volume":"492","author":"C Zhang","year":"2012","unstructured":"Zhang, C. et al. High-resolution crystal structure of human protease-activated receptor 1. Nature 492, 387\u2013392 (2012)","journal-title":"Nature"},{"key":"BFnature14287_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature11558","volume":"490","author":"JF White","year":"2012","unstructured":"White, J. F. et al. Structure of the agonist-bound neurotensin receptor. Nature 490, 508\u2013513 (2012)","journal-title":"Nature"},{"key":"BFnature14287_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.1194396","volume":"330","author":"B Wu","year":"2010","unstructured":"Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066\u20131071 (2010)","journal-title":"Science"},{"key":"BFnature14287_CR14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.1241475","volume":"341","author":"Q Tan","year":"2013","unstructured":"Tan, Q. et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science 341, 1387\u20131390 (2013)","journal-title":"Science"},{"key":"BFnature14287_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature10939","volume":"485","author":"H Wu","year":"2012","unstructured":"Wu, H. et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature 485, 327\u2013332 (2012)","journal-title":"Nature"},{"key":"BFnature14287_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume":"25","author":"J Ballesteros","year":"1995","unstructured":"Ballesteros, J. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366\u2013428 (1995)","journal-title":"Methods Neurosci."},{"key":"BFnature14287_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature13288","volume":"509","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Agonist-bound structure of the human P2Y12 receptor. Nature 509, 119\u2013122 (2014)","journal-title":"Nature"},{"key":"BFnature14287_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature13083","volume":"509","author":"K Zhang","year":"2014","unstructured":"Zhang, K. et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509, 115\u2013118 (2014)","journal-title":"Nature"},{"key":"BFnature14287_CR19","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1021\/jm049914c","volume":"47","author":"S Costanzi","year":"2004","unstructured":"Costanzi, S., Mamedova, L., Gao, Z. G. & Jacobson, K. A. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J. Med. Chem. 47, 5393\u20135404 (2004)","journal-title":"J. Med. Chem."},{"key":"BFnature14287_CR20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1021\/jm970684u","volume":"41","author":"S Moro","year":"1998","unstructured":"Moro, S. et al. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. 41, 1456\u20131466 (1998)","journal-title":"J. Med. Chem."},{"key":"BFnature14287_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ddr.10145","volume":"57","author":"D Guo","year":"2002","unstructured":"Guo, D., von K\u00fcgelgen, I., Moro, S., Kim, Y. C. & Jacobson, K. A. Evidence for the recognition of non-nucleotide antagonists within the transmembrane domains of the human P2Y1 receptor. Drug Dev. Res. 57, 173\u2013181 (2002)","journal-title":"Drug Dev. Res."},{"key":"BFnature14287_CR22","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1021\/jm4013906","volume":"56","author":"JX Qiao","year":"2013","unstructured":"Qiao, J. X. et al. Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1\u2032-neopentylspiro[indoline-3,4\u2032-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist. J. Med. Chem. 56, 9275\u20139295 (2013)","journal-title":"J. Med. Chem."},{"key":"BFnature14287_CR23","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1021\/jm5006226","volume":"57","author":"W Yang","year":"2014","unstructured":"Yang, W. et al. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents. J. Med. Chem. 57, 6150\u20136164 (2014)","journal-title":"J. Med. Chem."},{"key":"BFnature14287_CR24","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1016\/j.bmcl.2013.03.125","volume":"23","author":"TC Wang","year":"2013","unstructured":"Wang, T. C. et al. Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility. Bioorg. Med. Chem. Lett. 23, 3239\u20133243 (2013)","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnature14287_CR25","doi-asserted-by":"publisher","first-page":"e4382","DOI":"10.1371\/journal.pone.0004382","volume":"4","author":"PW Hildebrand","year":"2009","unstructured":"Hildebrand, P. W. et al. A ligand channel through the G protein coupled receptor opsin. PLoS ONE 4, e4382 (2009)","journal-title":"PLoS ONE"},{"key":"BFnature14287_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1215904","volume":"335","author":"MA Hanson","year":"2012","unstructured":"Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851\u2013855 (2012)","journal-title":"Science"},{"key":"BFnature14287_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature13494","volume":"513","author":"A Srivastava","year":"2014","unstructured":"Srivastava, A. et al. High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875. Nature 513, 124\u2013127 (2014)","journal-title":"Nature"},{"key":"BFnature14287_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature07063","volume":"454","author":"JH Park","year":"2008","unstructured":"Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H. W. & Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454, 183\u2013187 (2008)","journal-title":"Nature"},{"key":"BFnature14287_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature09648","volume":"469","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen, S. G. et al. Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature 469, 175\u2013180 (2011)","journal-title":"Nature"},{"key":"BFnature14287_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1126\/science.1202793","volume":"332","author":"F Xu","year":"2011","unstructured":"Xu, F. et al. Structure of an agonist-bound human A2A adenosine receptor. Science 332, 322\u2013327 (2011)","journal-title":"Science"},{"key":"BFnature14287_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.str.2012.04.010","volume":"20","author":"E Chun","year":"2012","unstructured":"Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967\u2013976 (2012)","journal-title":"Structure"},{"key":"BFnature14287_CR32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nprot.2009.31","volume":"4","author":"M Caffrey","year":"2009","unstructured":"Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706\u2013731 (2009)","journal-title":"Nature Protocols"},{"key":"BFnature14287_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D 66, 125\u2013132 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature14287_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007)","journal-title":"J. Appl. Crystallogr."},{"key":"BFnature14287_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240\u2013255 (1997)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature14287_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1107\/S0907444911056058","volume":"68","author":"OS Smart","year":"2012","unstructured":"Smart, O. S. et al. Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr. D 68, 368\u2013380 (2012)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature14287_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010)","journal-title":"Acta Crystallogr. D"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature14287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature14287","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature14287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:29:43Z","timestamp":1684420183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature14287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,30]]},"references-count":37,"journal-issue":{"issue":"7547","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["BFnature14287"],"URL":"https:\/\/doi.org\/10.1038\/nature14287","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,30]]},"assertion":[{"value":"19 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}